N-tert-butyl-3-fluorobenzenesulfonamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-tert-butyl-3-fluorobenzenesulfonamide
• 化学式: C₁₀H₁₄FNO₂S
• mdl: MFCD20043095
• 分子量: 231.291
• InChiKey: KLIHFUPIOJEEDZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-tert-butyl-3-fluorobenzenesulfonamide 在 甲醇 、 正丁基锂 、 硫酸 作用下， 以 四氢呋喃 、 环己烷 为溶剂， 反应 23.12h， 生成 4-methoxybenzo[d]isothiazol-3(2H)-one 1,1-dioxide
  参考文献：
  名称：

  Pseudosaccharin amines as potent and selective K V 1.5 blockers

  摘要：

  Phenethyl aminoheterocycles like compound 1 were known to be potent I-Kur blockers although they lacked potency in vivo. Modification of the heterocycle led to the design and synthesis of pseudosaccharin amines. Compounds such as 14, 17d and 21c were found to be potent K(V)1.5 blockers and selective over other cardiac ion channels. These compounds had potent pharmacodynamic activity, however, they also showed off-target activities such as hemodynamic effects. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.02.066
• 作为产物：
  描述：

  3-氟苯磺酰氯 、 叔丁胺 以 二氯甲烷 为溶剂， 生成 N-tert-butyl-3-fluorobenzenesulfonamide
  参考文献：
  名称：

  钴催化环 N-磺酰亚胺的对映选择性还原（杂）芳基化

  摘要：

  使用手性钴-双膦催化剂发现了使用芳基和杂芳基卤化物的亚胺不对称还原（杂）芳基化。这种方法补充了使用预制有机金属试剂的传统策略，并且在温和条件下表现出良好的官能团相容性。

  DOI：

  10.1002/anie.202300743

文献信息

• Bifunctional Amino Sulfonohydrazide Catalyzed Direct Asymmetric Mannich Reaction of Cyclic Ketimines with Ketones: Highly Diastereo- and Enantioselective Construction of Quaternary Carbon Stereocenters
  作者：Sheng Zhang、Lijun Li、Yanbin Hu、Zhenggen Zha、Zhiyong Wang、Teck-Peng Loh

  DOI：10.1021/acs.orglett.5b00196

  日期：2015.2.20

  sulfonohydrazide which contains multiple sites for hydrogen bonding with substrates was found to enhance reactivity and enantioselectivity in the direct asymmetric Mannich reaction of N-sulfonyl cyclic ketimines with ketones. In this efficient transformation, not only methyl ketones but also cyclic ketones can be employed to provide a general methodology to construct tetrasubstituted α-amino ester in a stereoselective

  发现双官能氨基磺酰肼包含多个与底物氢键合的位点，可在N-磺酰基环状酮亚胺与酮的直接不对称曼尼希反应中增强反应性和对映选择性。在这种有效的转化中，不仅可以使用甲基酮，而且可以使用环状酮来提供一般的方法来以立体选择性的方式构建四取代的α-氨基酯。取代的氨基酯产物的合成效用通过生物活性螺四氢呋喃的合成得到证明。
• AZA-HETEROARYL COMPOUNDS AS PI3K-GAMMA INHIBITORS
  申请人：Incyte Corporation

  公开号：US20160229843A1

  公开（公告）日：2016-08-11

  The present invention provides aza-heteroaryl derivatives of Formula I: and pharmaceutically acceptable salts thereof, wherein X, Y, Z, A, W, R 4 , R 5 , and R 6 are defined herein, that inhibit the activity of phosphoinositide 3-kinases-gamma (PI3Kγ) and are useful in the treatment of diseases related to the activity of PI3Kγ including, for example, autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  本发明提供了式I的氮杂杂环衍生物及其药学上可接受的盐，其中X、Y、Z、A、W、R4、R5和R6在此处定义，并且抑制磷脂酰肌醇3-激酶γ（PI3Kγ）的活性，并且在治疗与PI3Kγ活性相关的疾病方面具有用处，例如自身免疫疾病、癌症、心血管疾病和神经退行性疾病。
• Highly Enantioselective Construction of Fluoroalkylated Quaternary Stereocenters via Organocatalytic Dehydrated Mannich Reaction of Unprotected Hemiaminals with Ketones
  作者：Sheng Zhang、Lijun Li、Yanbin Hu、Yanan Li、Yu Yang、Zhenggen Zha、Zhiyong Wang

  DOI：10.1021/acs.orglett.5b02514

  日期：2015.10.16

  organocatalytic asymmetric dehydrated Mannich reaction of fluoroalkyl hemiaminals with ketones is reported. In this Mannich reaction, previously less explored aryl ketones showed great reactivity. By virtue of this efficient method, a wide range of biologically active β-amino ketones were directly obtained. More importantly, two different intermediates involved in the reaction were detected and identified by 19F

  报道了氟代烷基半缩醛与酮的一般有机催化不对称脱水曼尼希反应。在该曼尼希反应中，以前较少探索的芳基酮显示出很高的反应活性。通过这种有效的方法，直接获得了广泛的生物活性β-氨基酮。更重要的是，通过19 F NMR和HRMS分析检测并鉴定了参与反应的两种不同中间体。此外，通过生物活性的氟烷基β-氨基醇的合成证明了产物的合成效用。
• Aza-heteroaryl compounds as PI3K-gamma inhibitors
  申请人：Incyte Corporation

  公开号：US10022387B2

  公开（公告）日：2018-07-17

  The present invention provides aza-heteroaryl derivatives of Formula I: and pharmaceutically acceptable salts thereof, wherein X, Y, Z, A, W, R4, R5, and R6 are defined herein, that inhibit the activity of phosphoinositide 3-kinases-gamma (PI3Kγ) and are useful in the treatment of diseases related to the activity of PI3Kγ including, for example, autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  本发明提供了式 I 的杂己芳基衍生物： 及其药学上可接受的盐，其中 X、Y、Z、A、W、R4、R5 和 R6 在本文中定义，可抑制磷酸肌醇 3-激酶-γ（PI3Kγ）的活性，并可用于治疗与 PI3Kγ 活性有关的疾病，例如包括自身免疫性疾病、癌症、心血管疾病和神经退行性疾病。
• Pyrazolopyridine Compounds For IRE1 Inhibition
  申请人：Optikira, LLC

  公开号：US20220153734A1

  公开（公告）日：2022-05-19

  The present invention provides novel pyrazolopyridine compounds, compositions and methods for treating or preventing an IRE1α-related disease or disorder. In certain embodiments, the disease or disorder is selected from the group consisting of a neurodegenerative disease, a demyelinating disease, cancer, an eye disease, a fibrotic disease, and diabetes.